155 related articles for article (PubMed ID: 30245963)
21. Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer.
Emmanouilidi A; Fyffe CA; Ferro R; Edling CE; Capone E; Sestito S; Rapposelli S; Lattanzio R; Iacobelli S; Sala G; Maffucci T; Falasca M
J Exp Clin Cancer Res; 2019 May; 38(1):191. PubMed ID: 31088502
[TBL] [Abstract][Full Text] [Related]
22. Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast cancer.
Sahoo S; Brickley DR; Kocherginsky M; Conzen SD
Eur J Cancer; 2005 Nov; 41(17):2754-9. PubMed ID: 16246546
[TBL] [Abstract][Full Text] [Related]
23. PI3K signaling in cancer: beyond AKT.
Lien EC; Dibble CC; Toker A
Curr Opin Cell Biol; 2017 Apr; 45():62-71. PubMed ID: 28343126
[TBL] [Abstract][Full Text] [Related]
24. Functional role of SGK3 in PI3K/Pten driven liver tumor development.
Cao H; Xu Z; Wang J; Cigliano A; Pilo MG; Ribback S; Zhang S; Qiao Y; Che L; Pascale RM; Calvisi DF; Chen X
BMC Cancer; 2019 Apr; 19(1):343. PubMed ID: 30975125
[TBL] [Abstract][Full Text] [Related]
25. Role of serum- and glucocorticoid-inducible kinases in stroke.
Inoue K; Leng T; Yang T; Zeng Z; Ueki T; Xiong ZG
J Neurochem; 2016 Jul; 138(2):354-61. PubMed ID: 27123541
[TBL] [Abstract][Full Text] [Related]
26. Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma.
Liu M; Chen L; Chan TH; Wang J; Li Y; Li Y; Zeng TT; Yuan YF; Guan XY
Hepatology; 2012 Jun; 55(6):1754-65. PubMed ID: 22262416
[TBL] [Abstract][Full Text] [Related]
27. Targeting PDK1 in cancer.
Raimondi C; Falasca M
Curr Med Chem; 2011; 18(18):2763-9. PubMed ID: 21568903
[TBL] [Abstract][Full Text] [Related]
28. SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer.
Gasser JA; Inuzuka H; Lau AW; Wei W; Beroukhim R; Toker A
Mol Cell; 2014 Nov; 56(4):595-607. PubMed ID: 25458846
[TBL] [Abstract][Full Text] [Related]
29. The SIN1-PH Domain Connects mTORC2 to PI3K.
Yuan HX; Guan KL
Cancer Discov; 2015 Nov; 5(11):1127-9. PubMed ID: 26526694
[TBL] [Abstract][Full Text] [Related]
30. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
31. Chromatin regulation at the intersection of estrogen receptor and PI3K pathways in breast cancer.
Castel P; Toska E
Mol Cell Oncol; 2019; 6(6):e1625620. PubMed ID: 31692833
[TBL] [Abstract][Full Text] [Related]
32. The serum- and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin.
BelAiba RS; Djordjevic T; Bonello S; Artunc F; Lang F; Hess J; Görlach A
Circ Res; 2006 Mar; 98(6):828-36. PubMed ID: 16484615
[TBL] [Abstract][Full Text] [Related]
33. Post-translational regulation of EAAT2 function by co-expressed ubiquitin ligase Nedd4-2 is impacted by SGK kinases.
Boehmer C; Palmada M; Rajamanickam J; Schniepp R; Amara S; Lang F
J Neurochem; 2006 May; 97(4):911-21. PubMed ID: 16573659
[TBL] [Abstract][Full Text] [Related]
34. Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin.
Yu K; Toral-Barza L; Shi C; Zhang WG; Lucas J; Shor B; Kim J; Verheijen J; Curran K; Malwitz DJ; Cole DC; Ellingboe J; Ayral-Kaloustian S; Mansour TS; Gibbons JJ; Abraham RT; Nowak P; Zask A
Cancer Res; 2009 Aug; 69(15):6232-40. PubMed ID: 19584280
[TBL] [Abstract][Full Text] [Related]
35. Chemotactic activation of Dictyostelium AGC-family kinases AKT and PKBR1 requires separate but coordinated functions of PDK1 and TORC2.
Liao XH; Buggey J; Kimmel AR
J Cell Sci; 2010 Mar; 123(Pt 6):983-92. PubMed ID: 20200230
[TBL] [Abstract][Full Text] [Related]
36. The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation.
Haga S; Ozaki M; Inoue H; Okamoto Y; Ogawa W; Takeda K; Akira S; Todo S
Hepatology; 2009 Jan; 49(1):204-14. PubMed ID: 19065678
[TBL] [Abstract][Full Text] [Related]
37. PDK1, the master regulator of AGC kinase signal transduction.
Mora A; Komander D; van Aalten DM; Alessi DR
Semin Cell Dev Biol; 2004 Apr; 15(2):161-70. PubMed ID: 15209375
[TBL] [Abstract][Full Text] [Related]
38. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
39. Protein kinase Cζ exhibits constitutive phosphorylation and phosphatidylinositol-3,4,5-triphosphate-independent regulation.
Tobias IS; Kaulich M; Kim PK; Simon N; Jacinto E; Dowdy SF; King CC; Newton AC
Biochem J; 2016 Feb; 473(4):509-23. PubMed ID: 26635352
[TBL] [Abstract][Full Text] [Related]
40. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
